Exelixis (EXEL) Tax Rate Growth (3y) (2020 - 2026)

Exelixis (EXEL) Tax Rate Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,538.84 Bn 65,538.56 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
4 BeOne Medicines 469.46 Bn 464.67 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.69 Bn 115.45 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.41 Bn 61.65 Bn 3.31 Bn
7 Belite Bio 62.84 Bn 62.84 Bn -
8 Argenx Se 56.10 Bn 50.91 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.48 Bn 34.47 Bn 959.66 Mn
10 Exelixis 14.49 Bn 13.71 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 429.00
Jan 2, 2026 -76.00
Oct 3, 2025 285.00
Jul 4, 2025 -38.00
Apr 4, 2025 286.00
Jan 3, 2025 494.00
Sep 27, 2024 -450.00
Jun 28, 2024 -27.00
Mar 29, 2024 -15,520.00
Dec 29, 2023 -591.00
Sep 29, 2023 6,638.00
Jun 30, 2023 194.00
Mar 31, 2023 -194.00
Sep 30, 2022 -9.00
Jul 1, 2022 -62.00
Apr 1, 2022 311.00
Dec 31, 2021 22,879.00
Oct 1, 2021 2,647.00
Jul 2, 2021 2,204.00
Apr 2, 2021 17,733.00